Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dror Michaelson

Showing results (101-110 of 121) with videos related to

Pageof 13
Sort By:
European Urology Oncology|July 13, 2023
Long-term Outcomes of Chemoradiation for Muscle-invasive Bladder Cancer in Noncystectomy Candidates. Final Results of NRG Oncology RTOG 0524-A Phase 1/2 Trial of Paclitaxel + Trastuzumab with Daily Radiation or Paclitaxel Alone with Daily IrradiationDouglas M Dahl, Theodore G Karrison, M Dror Michaelson, et al.
International Journal of Radiation Oncology, Biology, Physics|July 25, 2025
Phase 3 Trial of Dose-Escalated Radiation Therapy and Standard Androgen Deprivation Therapy Versus Dose-Escalated Radiation Therapy and Enhanced Androgen Deprivation Therapy With Orteronel for Men With High-Risk Prostate Cancer (NRG/RTOG 1115)Daniel A Hamstra, James J Dignam, Deborah W Bruner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2016
Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell CarcinomaDavid J Kwiatkowski, Toni K Choueiri, André P Fay, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 27, 2009
NCCN clinical practice guidelines in oncology: testicular cancerRobert J Motzer, Neeraj Agarwal, Clair Beard, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 27, 2009
NCCN clinical practice guidelines in oncology: kidney cancerRobert J Motzer, Neeraj Agarwal, Clair Beard, et al.
Nature Medicine|September 8, 2020
Author Correction: Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomesPier Vitale Nuzzo, Jacob E Berchuck, Keegan Korthauer, et al.
Nature Medicine|June 24, 2020
Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomesPier Vitale Nuzzo, Jacob E Berchuck, Keegan Korthauer, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 10, 2017
Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in OncologyRobert J Motzer, Eric Jonasch, Neeraj Agarwal, et al.
Future Oncology (London, England)|April 11, 2019
The future of perioperative therapy in advanced renal cell carcinoma: how can we PROSPER?Hiten D Patel, Maneka Puligandla, Brian M Shuch, et al.
The Lancet. Oncology|May 15, 2023
Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysisAlexandre R Zlotta, Leslie K Ballas, Andrzej Niemierko, et al.
Pageof 13

Showing results (101-110 of 121) with videos related to

Sort By:
Pageof 13
European Urology Oncology|July 13, 2023
Long-term Outcomes of Chemoradiation for Muscle-invasive Bladder Cancer in Noncystectomy Candidates. Final Results of NRG Oncology RTOG 0524-A Phase 1/2 Trial of Paclitaxel + Trastuzumab with Daily Radiation or Paclitaxel Alone with Daily IrradiationDouglas M Dahl, Theodore G Karrison, M Dror Michaelson, et al.
International Journal of Radiation Oncology, Biology, Physics|July 25, 2025
Phase 3 Trial of Dose-Escalated Radiation Therapy and Standard Androgen Deprivation Therapy Versus Dose-Escalated Radiation Therapy and Enhanced Androgen Deprivation Therapy With Orteronel for Men With High-Risk Prostate Cancer (NRG/RTOG 1115)Daniel A Hamstra, James J Dignam, Deborah W Bruner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2016
Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell CarcinomaDavid J Kwiatkowski, Toni K Choueiri, André P Fay, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 27, 2009
NCCN clinical practice guidelines in oncology: testicular cancerRobert J Motzer, Neeraj Agarwal, Clair Beard, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 27, 2009
NCCN clinical practice guidelines in oncology: kidney cancerRobert J Motzer, Neeraj Agarwal, Clair Beard, et al.
Nature Medicine|September 8, 2020
Author Correction: Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomesPier Vitale Nuzzo, Jacob E Berchuck, Keegan Korthauer, et al.
Nature Medicine|June 24, 2020
Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomesPier Vitale Nuzzo, Jacob E Berchuck, Keegan Korthauer, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 10, 2017
Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in OncologyRobert J Motzer, Eric Jonasch, Neeraj Agarwal, et al.
Future Oncology (London, England)|April 11, 2019
The future of perioperative therapy in advanced renal cell carcinoma: how can we PROSPER?Hiten D Patel, Maneka Puligandla, Brian M Shuch, et al.
The Lancet. Oncology|May 15, 2023
Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysisAlexandre R Zlotta, Leslie K Ballas, Andrzej Niemierko, et al.
Pageof 13